TMAO in cardiovascular disease: Insights into its value as a biomarker

25 April 2026 (08:30 - 12:30)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Mr Octavian Amaritei

Emergency Hospital Galati, Galati (Romania)

72 More presentations in this session

Presentation thumbnail

Indexed neutrophil gelatinase associated lipocalin( NGAL) : improving prediction and ruling out of contrast-induced nephropathy

Professor Y. Shacham (Tel Aviv, IL)

Presentation thumbnail

Factors associated with hematoma formation after PCI in patients with acute myocardial infarction

Doctor G. Bytyci (Pristina, XK)

Abstract Slides

Presentation thumbnail

Charting thrombo-inflammatory signals: the platelet-to-monocyte ratio as a guide to arrhythmic risk in nstemi patients

Presentation thumbnail

Unmasking the hidden risks of coronary revascularization: Indonesian multicenter insights from INTERASPIRE on determinant factors driving major adverse cardiovascular events in acute coronary syndrome

Doctor I. Hergaf (West Jakarta, ID)

Abstract Slides

Presentation thumbnail

The promising role of Klotho and FGF23 proteins in the diagnosis of myocardial infarction in acute coronary syndrome

Assistant Professor A. Olejnik (Wroclaw, PL)

Abstract Slides

Access the full session

Session thumbnail

Poster session (3)

The Event

Event poster

ESC Preventive Cardiology 2026

25 April 2026 08:30 CET

You may be interested in

Webinar

Biomarkers of clinical utility in cardiovascular disease

Congress Session

Challenges and innovations in cardiovascular risk stratification with cardiac biomarkers

Webinar

Personalised secondary prevention post-ACS: the role of biomarkers

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources